# Advisor Review - Gemini-3-Flash

**Role:** Academic advisor checking for fatal errors
**Model:** gemini-3-flash-preview
**Paper:** paper.pdf
**Timestamp:** 2026-02-01T19:03:03.983466
**Route:** Direct Google API + PDF
**Tokens:** 21958 in / 584 out
**Response SHA256:** f063ec9cd6a4e328

---

I have reviewed the draft paper "Does Federal Transit Funding Improve Local Labor Markets? Evidence from a Population Threshold" for fatal errors. 

**ADVISOR REVIEW**

**1. DATA-DESIGN ALIGNMENT**
- **Treatment vs. Coverage:** The paper uses 2010 Census population to determine eligibility (FY 2012–2023) and evaluates outcomes using 2016–2020 ACS data. This is internally consistent; the treatment precedes and covers the outcome measurement period.
- **RDD Requirements:** The paper reports data on both sides of the 50,000 population cutoff (e.g., Table 2, Neff L/R columns).
- **Consistency:** The treatment definition (Section 5307 eligibility) is consistent throughout.

**2. REGRESSION SANITY**
- **Standard Errors:** All reported standard errors in Table 2, Table 3, and Table 4 are of plausible magnitude for the respective outcomes (e.g., SE = 0.0043 for a transit share outcome with a mean of 0.0074).
- **Coefficients:** Coefficients for percentage-based outcomes are small (mostly < 0.02), which is expected for log/fractional outcomes. No coefficients exceed the fatal error thresholds.
- **Impossible Values:** R-squared is not explicitly reported in the RDD tables, but no impossible values (R² < 0, negative SEs, or NaN/Inf) are present in the results tables.

**3. COMPLETENESS**
- **Placeholders:** No "TBD", "PLACEHOLDER", or "XXX" values were found in the text or tables.
- **N Reporting:** Effective sample sizes ($N_{eff}$) and full sample sizes are clearly reported in regression tables.
- **References:** Figures and tables mentioned in the text (e.g., Figure 1, Table 9) exist and are properly labeled.
- **Analyses:** Robustness checks described (bandwidth sensitivity, placebo tests, alternative kernels) are all supported by corresponding tables/figures.

**4. INTERNAL CONSISTENCY**
- **Numbers Match:** The statistics cited in the Abstract and Introduction (e.g., Transit share point estimate of -0.15 pp) match the coefficient reported in Table 2 (-0.0015).
- **Sample Sizes:** The total sample size (3,592) is consistent across Table 1, Table 5, and the main text.
- **Timing:** The FY 2012 treatment start and 2016–2020 outcome window are consistent across all sections.

**ADVISOR VERDICT: PASS**